New laser approach aims to stop melasma relapses

NCT ID NCT06644157

First seen Jan 02, 2026

Summary

This study tests whether a special 1064nm laser can treat melasma and prevent it from returning. Thirty adults with moderate to severe melasma will use a depigmenting cream and sunscreen on their whole face, while one side of the face also gets laser sessions every other week for 12 weeks. Researchers will compare the laser-treated side to the untreated side to see if the laser improves results and reduces relapses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELASMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU de Nice - Hôpital de l'Archet

    Nice, Alpes-Maritimes, 06200, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

1064nm 650 microsecond laser (Aerolase Neo Elite device)

What this could lead to

If successful, this laser treatment could reduce melasma severity and help prevent relapses when combined with standard depigmenting cream and sunscreen.

What could go wrong

This is a small early-stage study with only 30 participants, so results may not apply to everyone. The laser may cause temporary redness or discomfort, and melasma often returns without ongoing care.

Conditions

The condition(s) this trial relates to.

Melanosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.